180 related articles for article (PubMed ID: 15781963)
1. Orphanin FQ antagonizes the inhibition of Ca(2+) currents induced by mu-opioid receptors.
Zhang M; Wang X; Zhang D; Xu G; Dong H; Yu Y; Han J
J Mol Neurosci; 2005; 25(1):21-7. PubMed ID: 15781963
[TBL] [Abstract][Full Text] [Related]
2. Nociceptin/orphanin FQ and the opioid receptor-like ORL1 receptor.
Meunier JC
Eur J Pharmacol; 1997 Dec; 340(1):1-15. PubMed ID: 9527501
[TBL] [Abstract][Full Text] [Related]
3. Nociceptin/Orphanin-FQ Inhibits Gonadotropin-Releasing Hormone Neurons via G-Protein-Gated Inwardly Rectifying Potassium Channels.
Constantin S; Wray S
eNeuro; 2018; 5(6):. PubMed ID: 30627649
[TBL] [Abstract][Full Text] [Related]
4. OFQ reverses the kappa-opioid receptor-mediated depression of calcium current in rat dorsal root ganglion neurons.
Zhang M; Sun QL; Wan Y; Yao L; Yu YX; Han JS
Neuroreport; 1998 Jun; 9(9):2095-8. PubMed ID: 9674600
[TBL] [Abstract][Full Text] [Related]
5. Differential antagonism by naloxone benzoylhydrazone of the activation of inward rectifying K+ channels by nociceptin and a mu-opioid in rat periaqueductal grey slices.
Chiou LC
Naunyn Schmiedebergs Arch Pharmacol; 2001 Jun; 363(6):583-9. PubMed ID: 11414652
[TBL] [Abstract][Full Text] [Related]
6. Nociceptin/orphanin FQ modulation of ionic conductances in rat basal forebrain neurons.
Chin JH; Harris K; MacTavish D; Jhamandas JH
J Pharmacol Exp Ther; 2002 Oct; 303(1):188-95. PubMed ID: 12235250
[TBL] [Abstract][Full Text] [Related]
7. Opioid-related (ORL1) receptors are enriched in a subpopulation of sensory neurons and prolonged activation produces no functional loss of surface N-type calcium channels.
Murali SS; Napier IA; Rycroft BK; Christie MJ
J Physiol; 2012 Apr; 590(7):1655-67. PubMed ID: 22371475
[TBL] [Abstract][Full Text] [Related]
8. Binding and GTPgammaS autoradiographic analysis of preproorphanin precursor peptide products at the ORL1 and opioid receptors.
Neal CR; Owens CE; Taylor LP; Hoversten MT; Akil H; Watson SJ
J Chem Neuroanat; 2003 Jul; 25(4):233-47. PubMed ID: 12842269
[TBL] [Abstract][Full Text] [Related]
9. Nociceptin/orphanin FQ receptor expression in clinical pain disorders and functional effects in cultured neurons.
Anand P; Yiangou Y; Anand U; Mukerji G; Sinisi M; Fox M; McQuillan A; Quick T; Korchev YE; Hein P
Pain; 2016 Sep; 157(9):1960-1969. PubMed ID: 27127846
[TBL] [Abstract][Full Text] [Related]
10. Actions of nociceptin/orphanin FQ and other prepronociceptin products on rat rostral ventromedial medulla neurons in vitro.
Vaughan CW; Connor M; Jennings EA; Marinelli S; Allen RG; Christie MJ
J Physiol; 2001 Aug; 534(Pt 3):849-59. PubMed ID: 11483714
[TBL] [Abstract][Full Text] [Related]
11. Orphanin FQ/nociceptin-mediated desensitization of opioid receptor-like 1 receptor and mu opioid receptors involves protein kinase C: a molecular mechanism for heterologous cross-talk.
Mandyam CD; Thakker DR; Christensen JL; Standifer KM
J Pharmacol Exp Ther; 2002 Aug; 302(2):502-9. PubMed ID: 12130708
[TBL] [Abstract][Full Text] [Related]
12. Nociceptin/orphanin FQ decreases serotonin efflux in the rat brain but in contrast to a kappa-opioid has no antagonistic effect on mu-opioid-induced increases in serotonin efflux.
Tao R; Ma Z; Thakkar MM; McCarley RW; Auerbach SB
Neuroscience; 2007 Jun; 147(1):106-16. PubMed ID: 17499930
[TBL] [Abstract][Full Text] [Related]
13. The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence.
Witkin JM; Statnick MA; Rorick-Kehn LM; Pintar JE; Ansonoff M; Chen Y; Tucker RC; Ciccocioppo R
Pharmacol Ther; 2014 Mar; 141(3):283-99. PubMed ID: 24189487
[TBL] [Abstract][Full Text] [Related]
14. Orphanin FQ/nociceptin blocks chronic morphine-induced tyrosine hydroxylase upregulation.
Thakker DR; Standifer KM
Brain Res Mol Brain Res; 2002 Sep; 105(1-2):38-46. PubMed ID: 12399106
[TBL] [Abstract][Full Text] [Related]
15. Complete knockout of the nociceptin/orphanin FQ receptor in the rat does not induce compensatory changes in mu, delta and kappa opioid receptors.
Homberg JR; Mul JD; de Wit E; Cuppen E
Neuroscience; 2009 Sep; 163(1):308-15. PubMed ID: 19527777
[TBL] [Abstract][Full Text] [Related]
16. Dual coupling of opioid receptor-like (ORL1) receptors to adenylyl cyclase in the different layers of the rat main olfactory bulb.
Onali P; Ingianni A; Olianas MC
J Neurochem; 2001 Jun; 77(6):1520-30. PubMed ID: 11413235
[TBL] [Abstract][Full Text] [Related]
17. [Phe1psi(CH2-NH)Gly2]nociceptin-(1 - 13)-NH2 activation of an inward rectifier as a partial agonist of ORL1 receptors in rat periaqueductal gray.
Chiou LC
Br J Pharmacol; 1999 Sep; 128(1):103-7. PubMed ID: 10498840
[TBL] [Abstract][Full Text] [Related]
18. Quantitative study of [Tyr10]nociceptin/orphanin FQ (1-11) at NOP receptors in rat periaqueductal gray and expressed NOP receptors in HEK293 cells.
Liao YY; Lee CW; Ho IK; Chiou LC
Life Sci; 2012 Feb; 90(7-8):306-12. PubMed ID: 22213115
[TBL] [Abstract][Full Text] [Related]
19. 1-Benzyl-N-[3-[spiroisobenzofuran-1(3H),4'-piperidin-1-yl]propyl]pyrrolidine-2-carboxamide (Compound 24) antagonizes NOP receptor-mediated potassium channel activation in rat periaqueductal gray slices.
Liao YY; Trapella C; Chiou LC
Eur J Pharmacol; 2009 Mar; 606(1-3):84-9. PubMed ID: 19374842
[TBL] [Abstract][Full Text] [Related]
20. Mu-opioid-induced desensitization of opioid receptor-like 1 and mu-opioid receptors: differential intracellular signaling determines receptor sensitivity.
Mandyam CD; Thakker DR; Standifer KM
J Pharmacol Exp Ther; 2003 Sep; 306(3):965-72. PubMed ID: 12750434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]